412 related articles for article (PubMed ID: 33115909)
1. Will vaccination refusal prolong the war on SARS-CoV-2?
Marcec R; Majta M; Likic R
Postgrad Med J; 2021 Mar; 97(1145):143-149. PubMed ID: 33115909
[TBL] [Abstract][Full Text] [Related]
2. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
[TBL] [Abstract][Full Text] [Related]
3. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
Frederiksen LSF; Zhang Y; Foged C; Thakur A
Front Immunol; 2020; 11():1817. PubMed ID: 32793245
[TBL] [Abstract][Full Text] [Related]
4. Public awareness about coronavirus vaccine, vaccine acceptance, and hesitancy.
Elgendy MO; Abdelrahim MEA
J Med Virol; 2021 Dec; 93(12):6535-6543. PubMed ID: 34255346
[TBL] [Abstract][Full Text] [Related]
5. Lessons learned from the SARS-CoV-2 pandemic; from nucleic acid nanomedicines, to clinical trials, herd immunity, and the vaccination divide.
Hussain H; Ganesh A; Milane L; Amiji M
Expert Opin Drug Deliv; 2023 Apr; 20(4):489-506. PubMed ID: 36890642
[TBL] [Abstract][Full Text] [Related]
6. Evolution of Public Attitudes and Opinions Regarding COVID-19 Vaccination During the Vaccine Campaign in China: Year-Long Infodemiology Study of Weibo Posts.
Hong Y; Xie F; An X; Lan X; Liu C; Yan L; Zhang H
J Med Internet Res; 2023 Feb; 25():e42671. PubMed ID: 36795467
[TBL] [Abstract][Full Text] [Related]
7. Attitudes towards vaccines and intention to vaccinate against COVID-19: a cross-sectional analysis-implications for public health communications in Australia.
Enticott J; Gill JS; Bacon SL; Lavoie KL; Epstein DS; Dawadi S; Teede HJ; Boyle J;
BMJ Open; 2022 Jan; 12(1):e057127. PubMed ID: 34980631
[TBL] [Abstract][Full Text] [Related]
8. Messages that increase COVID-19 vaccine acceptance: Evidence from online experiments in six Latin American countries.
Argote Tironi P; Barham E; Zuckerman Daly S; Gerez JE; Marshall J; Pocasangre O
PLoS One; 2021; 16(10):e0259059. PubMed ID: 34710168
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials.
Lim HX; Arip M; Yahaya AAA; Jazayeri SD; Poppema S; Poh CL
Front Biosci (Landmark Ed); 2021 Nov; 26(11):1286-1304. PubMed ID: 34856768
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 vaccines: concerns beyond protective efficacy and safety.
Lai CC; Chen IT; Chao CM; Lee PI; Ko WC; Hsueh PR
Expert Rev Vaccines; 2021 Aug; 20(8):1013-1025. PubMed ID: 34180347
[TBL] [Abstract][Full Text] [Related]
11. Challenges of vaccination and herd immunity in COVID-19 and management strategies.
She J; Hou D; Chen C; Bi J; Song Y
Clin Respir J; 2022 Nov; 16(11):708-716. PubMed ID: 36172975
[TBL] [Abstract][Full Text] [Related]
12. Pediatric and Parents' Attitudes Towards COVID-19 Vaccines and Intention to Vaccinate for Children.
Choi SH; Jo YH; Jo KJ; Park SE
J Korean Med Sci; 2021 Aug; 36(31):e227. PubMed ID: 34402237
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
14. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 variants and the global pandemic challenged by vaccine uptake during the emergence of the Delta variant: A national survey seeking vaccine hesitancy causes.
AlJamaan F; Temsah MH; Alhasan K; Alenezi S; Alhaboob A; Alrabiaah A; Batais M; Alshahrani F; Assiri RA; Bafaqih H; Alaraj A; Al Qadrah B; Alhaidary A; Saad K; Saddik B; Halwani R; Rabaan AA; Al-Subaie S; Barry M; Al-Tawfiq JA
J Infect Public Health; 2022 Jul; 15(7):773-780. PubMed ID: 35728424
[TBL] [Abstract][Full Text] [Related]
16. How to think about severe acute respiratory syndrome coronavirus 2 vaccination for pregnant and lactating women in China.
Li P; Liu H; Zou Y; Fang M; Chen Y; Zhang W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 46(12):1386-1391. PubMed ID: 35232909
[TBL] [Abstract][Full Text] [Related]
17. Willingness to take COVID-19 vaccination in low-income countries: Evidence from Ethiopia.
Strupat C; Shigute Z; Bedi AS; Rieger M
PLoS One; 2022; 17(3):e0264633. PubMed ID: 35239711
[TBL] [Abstract][Full Text] [Related]
18. Change in willingness to COVID-19 vaccination in China: Two online surveys during the pandemic.
Huang N; Wang C; Han B; Zhao T; Liu B; Chen L; Xie M; Zheng H; Zhang S; Wang Y; Juan D; Liu Y; Lu Q; Cui F
J Med Virol; 2022 Nov; 94(11):5271-5278. PubMed ID: 35848516
[TBL] [Abstract][Full Text] [Related]
19. Of Mice and Schoolchildren: A Conceptual History of Herd Immunity.
Robertson D
Am J Public Health; 2021 Aug; 111(8):1473-1480. PubMed ID: 34111938
[TBL] [Abstract][Full Text] [Related]
20. Potential for elimination of SAR-CoV-2 through vaccination as inspired by elimination of multiple influenza viruses through natural pandemics or mass vaccination.
Chen JM; Sun YX; Chen JW
J Med Virol; 2020 Nov; 92(11):2453-2457. PubMed ID: 32525587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
